Genotype-function-phenotype correlations for SCN1A variants identified by clinical genetic testing.

Area of Science:

• Neurogenetics
• Computational Neuroscience
• Clinical Genetics

Background:

• Genetic testing identifies SCN1A variants in 25% of pediatric epilepsy cases.
• Variants of uncertain significance limit accurate diagnosis and treatment.
• Functional studies are crucial for distinguishing pathogenic from benign SCN1A variants.

Purpose of the Study:

• To correlate genotype, function, and phenotype in children with SCN1A-associated epilepsy.
• To utilize automated patch clamp and computational modeling to interpret SCN1A variants.
• To improve understanding of SCN1A epilepsy and guide clinical management.

Main Methods:

• Extracted clinical data from children with SCN1A variants.
• Assessed functional properties of Na_V1.1 variant channels using automated patch clamp.
• Integrated functional data into a computational model of parvalbumin-positive interneurons to simulate firing patterns.

Main Results:

• Six of nine non-truncating SCN1A variants showed complete loss of function (LoF).
• Two variants displayed partial LoF or mixed function; one showed normal function.
• Functional data reclassified six variants; complete LoF correlated with early seizure onset, febrile seizures, drug-resistant epilepsy, and cognitive deficits.

Conclusions:

• Functional analysis and neuron simulations resolved variants of uncertain significance in SCN1A epilepsy.
• These methods correlated SCN1A variant function with clinical phenotype and medication response.
• This integrated approach enhances genotype-phenotype correlation for SCN1A-related epilepsies.